Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 07 Mar 2023

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection

in Vaccines and Molecular Therapeutics

Hakjun Hyun
A-Yeung Jang
Heedo Park
Jung Yeon Heo
Yu Bin Seo
Eliel Nham
Jin Gu Yoon
Hye Seong
Ji Yun Noh
Hee Jin Cheong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1131229

3,517 views
11 citations

Systematic Review

Published on 07 Mar 2023

Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials

in Vaccines and Molecular Therapeutics

Patrick M. McCarthy
Franklin A. Valdera
Todd R. Smolinsky
Alexandra M. Adams
Anne E. O’Shea
Katryna K. Thomas
Spencer Van Decar
Elizabeth L. Carpenter
Ankur Tiwari
John W. Myers

Frontiers in Immunology

doi 10.3389/fimmu.2023.1090533

4,658 views
11 citations

Correction

Published on 07 Mar 2023

Corrigendum: SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from the University Hospital in Krakow, Poland

in Vaccines and Molecular Therapeutics

Izabella Owsianka
Agnieszka Pac
Estera Jachowicz
Karolina Gutkowska
Wiktor Szczuciński
Barbara Maziarz
Elżbieta Sochacka-Tatara
Piotr Heczko
Wojciech Sydor
Barbara Żółtowska

Frontiers in Immunology

doi 10.3389/fimmu.2023.1155871

1,195 views

Brief Research Report

Published on 06 Mar 2023

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study

in Vaccines and Molecular Therapeutics

Sabrina Manni
Caroline Ruetsch
Roxane Fabre
Michel Ticchioni
Daisy Graça
Christian Pradier
Barbara Seitz-Polski
Laurene Lotte
Vesna Brglez
Matteo Vassallo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1136723

2,376 views
2 citations

Original Research

Published on 06 Mar 2023

Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents

in Vaccines and Molecular Therapeutics

Daniel Leung
Carolyn A. Cohen
Xiaofeng Mu
Jaime S. Rosa Duque
Samuel M. S. Cheng
Xiwei Wang
Manni Wang
Wenyue Zhang
Yanmei Zhang
Issan Y. S. Tam

Frontiers in Immunology

doi 10.3389/fimmu.2023.1106837

4,080 views
10 citations

Systematic Review

Published on 03 Mar 2023

A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults

in Vaccines and Molecular Therapeutics

Kun Xu
Zihan Wang
Maorong Qin
Yangyu Gao
Na Luo
Wanting Xie
Yihan Zou
Jie Wang
Xingming Ma

Frontiers in Immunology

doi 10.3389/fimmu.2023.1113156

20,173 views
51 citations

Original Research

Published on 03 Mar 2023

Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter, longitudinal study

in Vaccines and Molecular Therapeutics

Youhua Yuan
Junhong Xu
Bing Ma
Guohua Chen
Zhibin Wang
Shanmei Wang
Nan Jing
Jiangfeng Zhang
Baoya Wang
Wenjuan Yan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1107866

2,860 views
12 citations

Original Research

Published on 02 Mar 2023

Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections

in Vaccines and Molecular Therapeutics

Jinyoung Yang
Gunho Won
Jin Yang Baek
Young Ho Lee
Haein Kim
Kyungmin Huh
Sun Young Cho
Cheol-In Kang
Doo Ryeon Chung
Kyong Ran Peck

Frontiers in Immunology

doi 10.3389/fimmu.2023.1139980

2,830 views
10 citations

Clinical Trial

Published on 02 Mar 2023

Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV

in Vaccines and Molecular Therapeutics

Yi Wang
Jianhua Li
Wenhui Zhang
Shourong Liu
Liangbin Miao
Zhaoyi Li
Ai Fu
Jianfeng Bao
Lili Huang
Liping Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2023.1152695

2,890 views
10 citations

Original Research

Published on 02 Mar 2023

Comparison of humoral and cellular immune responses between ChAd-BNT heterologous vaccination and BNT-BNT homologous vaccination following the third BNT dose: A prospective cohort study

in Vaccines and Molecular Therapeutics

Wooho Sim
Hyunhye Kang
Jin Jung
Jihyun Lee
Geon Young Ko
Hye-Sun Park
Jeewan Choi
Kinam Park
Eun-Jee Oh

Frontiers in Immunology

doi 10.3389/fimmu.2023.1120556

4,024 views
14 citations

Original Research

Published on 02 Mar 2023

Identification of genes related to immune enhancement caused by heterologous ChAdOx1–BNT162b2 vaccines in lymphocytes at single-cell resolution with machine learning methods

in Vaccines and Molecular Therapeutics

Jing Li
FeiMing Huang
QingLan Ma
Wei Guo
KaiYan Feng
Tao Huang
Yu-Dong Cai

Frontiers in Immunology

doi 10.3389/fimmu.2023.1131051

5,877 views
9 citations

Original Research

Published on 01 Mar 2023

SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study

in Vaccines and Molecular Therapeutics

Jeroen Geldof
Marie Truyens
João Sabino
Marc Ferrante
Jo Lambert
Hilde Lapeere
Tom Hillary
An Van Laethem
Kurt de Vlam
Patrick Verschueren

Frontiers in Immunology

doi 10.3389/fimmu.2023.1126351

4,362 views
6 citations

Brief Research Report

Published on 28 Feb 2023

Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice

in Vaccines and Molecular Therapeutics

Charu Aggarwal
Viswanathan Ramasamy
Amit Garg
Rahul Shukla
Navin Khanna

Frontiers in Immunology

doi 10.3389/fimmu.2023.1128784

5,276 views
5 citations

Original Research

Published on 28 Feb 2023

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

in Vaccines and Molecular Therapeutics

Joanna Waldock
Carol D. Weiss
Wei Wang
Min Z. Levine
Stacie N. Jefferson
Sammy Ho
Katja Hoschler
Brandon Z. Londt
Elisa Masat
Louise Carolan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1129765

3,223 views
5 citations

Mini Review

Published on 28 Feb 2023

New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF

in Vaccines and Molecular Therapeutics

Zhi-Yan Liu
Min-Xue Sun
Man-Qi Hua
Han-Xu Zhang
Guang-Yan Mu
Shuang Zhou
Zhe Wang
Qian Xiang
Yi-Min Cui

Frontiers in Immunology

doi 10.3389/fimmu.2023.1098665

7,641 views
17 citations

Brief Research Report

Published on 28 Feb 2023

Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose

in Vaccines and Molecular Therapeutics

Luca Perico
Marta Todeschini
Federica Casiraghi
Marilena Mister
Anna Pezzotta
Tobia Peracchi
Susanna Tomasoni
Piera Trionfini
Ariela Benigni
Giuseppe Remuzzi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1123158

3,838 views
8 citations